D. Johnson
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Lung Cancer Treatments and Mutations, Venous Thromboembolism Diagnosis and Management, Mitochondrial Function and Pathology, Liver Disease and Transplantation
Most-Cited Works
- → Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer(1995)714 cited
- → Mitochondrial Matrix Phosphoproteome: Effect of Extra Mitochondrial Calcium(2006)262 cited
- → Tissue heterogeneity of the mammalian mitochondrial proteome(2006)208 cited
- → A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage 1B and II non small cell lung cancer (NSCLC) Intergroup JBR.10(2004)124 cited
- → Functional consequences of mitochondrial proteome heterogeneity(2006)110 cited
- → Immunotherapy and the Interventional Oncologist: Challenges and Opportunities—A Society of Interventional Oncology White Paper(2019)74 cited
- → Chapter 4 32P Labeling of Protein Phosphorylation and Metabolite Association in the Mitochondria Matrix(2009)52 cited
- → Use of 32P To Study Dynamics of the Mitochondrial Phosphoproteome(2009)42 cited
- → ABX-EGF in combination with paclitaxel and carboplatin for advanced non-small cell lung cancer (NSCLC)(2004)40 cited
- → Proteomic changes associated with diabetes in the BB-DP rat(2008)37 cited